01 January 2001
Effect of different drugs on the level of DNA-hydrolyzing polyclonal IgG antibodies in sera of patients with Hashimoto's thyroiditis and nontoxic nodal goiter.
Gregory A Nevinsky, Alexander A Breusov, Andrey G Baranovskii, Alrxander V Prints, Tatyana G Kanyshkova, Anastasiya V Galvita, Valerii A Naumov, Valentina N BunevaMed Sci Monit 2001; 7(2): BR201-211 :: ID: 421162
Abstract
BACKGROUND: DNA-hydrolyzing IgG antibodies have been detected recentlyin the sera of patients with several autoimmune diseases.
MATERIAL AND METHODS: The relative activityof DNA-hydrolyzing IgG from the sera of patients with Hashimoto's thyroiditis and with non-toxic nodalgoiter as a function of the patient's condition were measured. The effect of different drugs on the levelof DNA-hydrolyzing IgG, functional activity of thyroid gland, and improvement of clinical condition oftwo groups of patients were analyzed.
RESULTS: We demonstrate here for the first time that IgG from peripheralblood of patients with Hashimoto's thyroiditis (65%) and non-toxic nodal goiter (38%) possesses DNAseactivity. The relative level-specific activity of IgGs in hydrolysis of DNA increases with the enhancementof the relative amount of antibodies against thyroglobulin and all patients with hypothyroidism (namelya reduced concentration of thyroxine and triiodothyronine and enhanced level of thyrotropic hormone)are characterized by a high level of catalytic antibodies.
CONCLUSIONS: The very widely used therapyof patients with thyroxine led only to a temporary change of the hormone concentration in the blood butdid not affect the level of DNA-hydrolyzing antibodies. However, treatment with an immunosuppressivedrug plaquenil (7-chloro-4(beta-diethylamine-alpha-methylbutylamie)quinoline), significantly decreasedthe DNA-hydrolyzing activity of Abs, which correlated with enhancement of thyroid hormone concentrations,elevation of functional activity of the thyroid gland, and improvement of the clinical state of the patients.
Keywords: Hashimoto, nontoxic nodal goiter, catalytic antibodies, DNAse activity, different drug treatment
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952